Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer

TNBC (Triple Negative Breast Cancer) is a subtype of breast cancer with an aggressive phenotype which shows high metastatic capability and poor prognosis. Owing to its intrinsic properties like heterogeneity, lack of hormonal receptors and aggressive phenotype leave chemotherapy as a mainstay for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalakur-Ramireddy, Naveen K.R., Pakala, Suresh B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789156/
https://www.ncbi.nlm.nih.gov/pubmed/29298879
http://dx.doi.org/10.1042/BSR20171357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789156/
https://www.ncbi.nlm.nih.gov/pubmed/29298879
http://dx.doi.org/10.1042/BSR20171357

Ejemplares similares